Relationship between nonalcoholic fatty liver disease (NAFLD) susceptibility genes and plasma ALT, triglycerides, sE‐selectin and sVCAM levels in the combined Cohort on Diabetes and Atherosclerosis Maastricht and Hoorn studies. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.